Simplify Asset Management’s Ovid Therapeutics OVID Stock Holding History

Simplify Asset Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-130,813	Closed	-$290K	–	154
2026 Q1	$290K	Buy	+130,813	New	+$234K	﹤0.01%	123

Other funds holding OVID

BMC

Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return

Simplify Asset Management's OVID Position: Q2 2026 in Review

Simplify Asset Management sold out of Ovid Therapeutics (OVID) in Q2 2026, closing a stake of 130,813 shares — an estimated $290K sold.

Simplify Asset Management first reported a position in OVID in Q1 2026 and held it in 1 quarter. The position peaked at $290K in Q1 2026. 3 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

Simplify Asset Management reported no remaining Ovid Therapeutics position as of Q2 2026 after selling out during the quarter.
Simplify Asset Management sold 130,813 Ovid Therapeutics shares in Q2 2026, an estimated $290K.
Simplify Asset Management first reported a position in Ovid Therapeutics in Q1 2026 and held it in 1 quarter.
Simplify Asset Management's Ovid Therapeutics position peaked at $290K in Q1 2026.
3 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.